CompletedPHASE1, PHASE2NCT06159686

The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus

Studying Uremic pruritus

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Thammasat University Hospital
Principal Investigator: Suthiya Anumas
Thammasat University
Intervention: Hemp(drug)
Enrollment: 60 target
Eligibility: 18 years · All sexes
Timeline: 2023 – 2023

Study locations (1)

Thammasat, Pathum Thani, Thailand

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06159686 on ClinicalTrials.gov

Other trials for Uremic pruritus

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT06446310
Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
Qilu Pharmaceutical (Hainan) Co., Ltd.

See all trials for Uremic pruritus →

← Back to all trials